Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Erik K. Flemington PhD
Genes X Environment
Tulane University School of Medicine
Maryam Foroozesh PhD
Translational Oncology
Xavier University
Omar Franco, PhD
Cancer Biology
LSU Health - Shreveport
Gloria Giarratano, PhD
Population Sciences
LSU Health - New Orleans
W T. Godbey PhD
Translational Oncology
Tulane University School of Medicine
Galina Goloverda PhD
Translational Oncology
Xavier University
Loren Gragert, PhD
Population Sciences
Tulane University School of Medicine
Stefan Grant MD
Translational Oncology
Tulane University School of Medicine
Tyra Gross PhD
Population Sciences
Xavier University